RFTech Co., Ltd. Bionanotechnology Co., Ltd. and Lee Gyeong Sook agreed to acquire a 32.69% stake in Enterpartners Co., LTD (KOSDAQ:A058450) from Kyung Nam Pharm Co.,Ltd. (KOSDAQ:A053950) for KRW 23 billion on April 12, 2024. The consideration will be paid at a price of KRW 6 billion per share. As of April 15, 2024, RFTech Co., Ltd, Bionanotechnology Co., Ltd. and Lee Gyeong Sook have acquired a combined 5.75% stake.

As of May 22, 2024, the transaction price has been revised to KRW 30 billion and the shares acquired have been increased to 5.6 million shares. Enterpartners reported total assets of KRW 425.6 billion at the end of 2023 fiscal year. The transaction is expected to close on May 23, 2024.

The closing date was extended to August 30, 2024.